Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate IQVIA Holdings Inc. before investing.

In this article, we go over a few key elements for understanding IQVIA Holdings Inc.’s stock price such as:

• IQVIA Holdings Inc.’s current stock price and volume
• Why IQVIA Holdings Inc.’s stock price changed recently
• Upgrades and downgrades for IQV from analysts
• IQV’s stock price momentum as measured by its relative strength

About IQVIA Holdings Inc. (IQV)

Before we jump into IQVIA Holdings Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

Want to learn more about IQVIA Holdings Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about IQVIA Holdings Inc..

IQVIA Holdings Inc.’s Stock Price as of Market Close

As of May 21, 2026, 1:02 PM, CST, IQVIA Holdings Inc.’s stock price was $168.130.

IQVIA Holdings Inc. is down 1.97% from its previous closing price of $171.500.

During the last market session, IQVIA Holdings Inc.’s stock traded between $166.580 and $170.630. Currently, there are approximately 168.40 million shares outstanding for IQVIA Holdings Inc..

IQVIA Holdings Inc.’s price-earnings (P/E) ratio is currently at 21.2, which is low compared to the Life Sciences Tools & Services industry median of 33.2. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

IQVIA Holdings Inc. Stock Price History

IQVIA Holdings Inc.’s (IQV) price is currently up 6.16% so far this month.

During the month of May, IQVIA Holdings Inc.’s stock price has reached a high of $182.700 and a low of $156.240.

Over the last year, IQVIA Holdings Inc. has hit prices as high as $247.045 and as low as $134.645. Year to date, IQVIA Holdings Inc.’s stock is down 25.41%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused IQVIA Holdings Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 20, 2026, there was 1 analyst who downgraded IQVIA Holdings Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate IQVIA Holdings Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on IQVIA Holdings Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

IQVIA Holdings Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about IQVIA Holdings Inc. (IQV) by visiting AAII Stock Evaluator.

Relative Price Strength of IQVIA Holdings Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 20, 2026, IQVIA Holdings Inc. has a weighted four-quarter relative price strength of -0.40%, which translates to a Momentum Score of 61 and is considered to be Strong.

Want to learn more about how IQVIA Holdings Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

IQVIA Holdings Inc. Stock Price: Bottom Line

As of May 21, 2026, IQVIA Holdings Inc.’s stock price is $168.130, which is down 1.97% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like IQVIA Holdings Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.